Slobodan M Jankovic (Slobodan Janković, Slobodan M Janković, Slobodan Jankovic)

Scopus Author ID ResearcherID ORCID

Publication Activity (10 Years)

Years Active: 2017-2023
Publications (10 Years): 38

Top Venues

Journal of chemotherapy (Florence, Italy)

Medicina (Kaunas, Lithuania)

Expert review of neurotherapeutics

Expert opinion on drug metabolism & toxicology

University of Kragujevac

University of Belgrade (MSC)

This page only lists publications with an associated author ORCID identifier.

Affiliation History

University of Kragujevac Aug 1o 1987

Serbia

Professor :: Faculty of Medical Sciences

Education History

University of Belgrade Oct 1o 1988 - Sep 30o 1990

Serbia

MSC :: Center for multidisciplinar studies

Publications

Marija Jovičić, Aleksandra Dimitrijević, Marko M Folic, Radiša Pavlović, Slobodan M Jankovic
Predictors of Mortality in Early Neonatal Sepsis: A Single-Center Experience. Medicina (Kaunas, Lithuania) 59 (3) (2023)
Marija Jovičić, Aleksandra Dimitrijević, Marko M Folic, Radiša Pavlović, Slobodan M Jankovic
Predictors of Mortality in Early Neonatal Sepsis: A Single-Center Experience. Medicina (Kaunas, Lithuania) 59 (3) (2023)
Branislava Raičević, Snežana Janković, Refet Gojak, Vera Dabanović, Slobodan M Jankovic
Long-term outcomes in refractory status epilepticus. Expert review of neurotherapeutics (2023)
Marija Jovičić, Aleksandra Dimitrijević, Marko M Folic, Radiša Pavlović, Slobodan M Jankovic
Predictors of Mortality in Early Neonatal Sepsis: A Single-Center Experience. Medicina (Kaunas, Lithuania) 59 (3) (2023)
Ivana Stević, Nemanja Petrović, Slobodan M Jankovic
Bioequivalence of Different Formulations of Zonisamide Oral Suspensions: A Short Review. Patient preference and adherence 17 (2023)
Slobodan M Jankovic, Siniša Stojković, Milovan Petrović, Tomislav Kostić, Marija Zdravković, Slavica Radovanović, Radosava Cvjetan, Nenad Ratković, Branislav Rihor, Dejan Spiroski, Aleksandar Stanković, Branko Anđelković, Renata Gocić Petrović
Results of the trycort: Cohort study of add-on antihypertensives for treatment of resistant hypertension. Medicine 102 (22) (2023)
Slobodan M Jankovic, Snežana V Janković
Clinical Pharmacokinetics and Pharmacodynamics of Esaxerenone, a Novel Mineralocorticoid Receptor Antagonist: A Review. European journal of drug metabolism and pharmacokinetics 47 (3) (2022)
Ana V Pejcic, Aleksandra Dimitrijević, Marko Folic, Diana Fernandes, João Bentes, Miralem Djesevic, Slobodan M Jankovic
Amoxicillin-associated Stevens-Johnson syndrome or toxic epidermal necrolysis: systematic review. Journal of chemotherapy (Florence, Italy) (2022)
Slobodan M Jankovic, Miralem Đešević
Advancements in neuroactive peptides in seizures. Expert review of neurotherapeutics 22 (2) (2022)
Zorica Lazic, Ivana Stankovic, Branislava Milenkovic, Biljana S Zvezdin, Sanja Hromis, Slobodan M Jankovic, Vojislav Cupurdija
Characteristics of COPD Phenotypes in Serbia. International journal of chronic obstructive pulmonary disease 16 (2021)
Jasmina R Milovanovic, Olivera Z Milovanovic, Aleksandra Tomic Lucic, Jelena Djokovic, Tatjana Cvetkovic, Slavoljub Zivanovic, Ana Barjaktarevic, Suzana Pantovic, Milan Radovanovic, Aleksandra Dimitrijevic, Slobodan M Jankovic, Radmila Velickovic Radovanovic
The significant role of dietary intake of vitamin D in non-menopausal women health. Women & health 61 (5) (2021)
Slobodan M Jankovic, Miralem Dješević, Snežana V Janković
Experimental GABA A Receptor Agonists and Allosteric Modulators for the Treatment of Focal Epilepsy. Journal of experimental pharmacology 13 (2021)
Andjelka Stojkovic, Katerina Dajic, Jasmina Milovanovic, Slobodan M Jankovic, Nenad V Markovic, Andrijana Kostic
Effects of Supplementation in Vitamin D3 Deficient or Insufficient Children with Allergic Diseases. Medicina (Kaunas, Lithuania) 57 (10) (2021)
Slobodan M Jankovic, Nenad Marković, Tanja Luković
Treating of focal epilepsy: a patent review. Pharmaceutical patent analyst 10 (3) (2021)
Slobodan M Jankovic
Personalization of drug dose thematic issue: introduction article. Expert opinion on drug metabolism & toxicology (2021)
Dejan Z Aleksić, Aleksandra Dimitrijević, Srđan M Stefanović, Andriana Bukonjić, Jovana Z Milosavljević, Slobodan M Jankovic, Ivo Božović, Stojan Perić, Dragana Lavrnić
Risk factors for potential drug-drug interactions in patients with myasthenia gravis. Neurological research 43 (12) (2021)
Ana V Pejcic, Slobodan M Jankovic, Miralem Đešević, Refet Gojak, Snežana Lukić, Nenad Marković, Aleksandra Dimitrijević
Novel and emerging therapeutics for genetic epilepsies. Expert review of neurotherapeutics 21 (11) (2021)
Slobodan M Jankovic, Radica Zivkovic Zaric, Katarina Krasic, Valentina Opancina, Nikola Nedovic, Marija Zivkovic Radojevic
New instrument for measuring quality of life in patients with cervical cancer. Health care for women international 42 (7-9) (2021)
Romana Suša, Vojislav Cupurdija, Ljiljana Novković, Miloš Ratinac, Slobodan M Jankovic, Danijela Đoković, Jovan Jovanović, Katarina Pantić, Stefan M Simovic, Danijela Bazić-Sretenović, Ivan Čekerevac
Does the Severity of Obstructive Sleep Apnea Have an Independent Impact on Systemic Inflammation? Medicina (Kaunas, Lithuania) 57 (3) (2021)
Slobodan Obradovic, Edin Begic, Slobodan M Jankovic, Radoslav Romanovic, Nemanja Djenic, Boris Dzudovic, Zoran Jovic, Dragana Malovic, Vesna Subota, Milena Stavric, Farid Ljuca, Zumreta Kusljugic
Association of PC and AT levels in the early phase of STEMI treated with pPCI with LV systolic function and 6-month MACE. Acta clinica Belgica (2020)
Miroslav Stojadinovic, Teodora Trifunovic, Slobodan M Jankovic
Adaptation of the prostate biopsy collaborative group risk calculator in patients with PSA less than 10 ng/ml improves its performance. International urology and nephrology 52 (10) (2020)
Slobodan M Jankovic
Evaluation of zonisamide for the treatment of focal epilepsy: a review of pharmacokinetics, clinical efficacy and adverse effects. Expert opinion on drug metabolism & toxicology 16 (3) (2020)
Slobodan M Jankovic
A Critique of Pharmacokinetic Calculators for Drug Dosing Individualization. European journal of drug metabolism and pharmacokinetics 45 (2) (2020)
Slobodan M Jankovic, Snežana V Janković
Lessons learned from the discovery of sodium valproate and what has this meant to future drug discovery efforts? Expert opinion on drug discovery 15 (11) (2020)
Marko M Folic, Zorana Djordjevic, Nevena Folic, Marija Zivkovic Radojevic, Slobodan M Jankovic
Epidemiology and risk factors for healthcare-associated infections caused by Pseudomonas aeruginosa. Journal of chemotherapy (Florence, Italy) 33 (5) (2020)
Miroslav Stojadinovic, Ivan Vukovic, Milos Ivanovic, Milorad Stojadinovic, Dragan Milovanovic, Damnjan Pantic, Slobodan M Jankovic
Optimal threshold of the prostate health index in predicting aggressive prostate cancer using predefined cost-benefit ratios and prevalence. International urology and nephrology 52 (5) (2019)
Jasmina R Milovanović, Slobodan M Jankovic, Dragan Milovanović, Dejana Ružić Zečević, Marko Folić, Marina Kostić, Goran Ranković, Srđan Stefanović
Contemporary surgical management of drug-resistant focal epilepsy. Expert review of neurotherapeutics 20 (1) (2019)
Marija V Anđelković, Slobodan M Jankovic, Marina J Kostić, Radica S Živković Zarić, Valentina D Opančina, Milos Z Zivic, Ana V Pejcic
Antimicrobial treatment of Stenotrophomonas maltophilia invasive infections: Systematic review. Journal of chemotherapy (Florence, Italy) 31 (6) (2019)
Radica S Živković Zarić, Ana V Pejcic, Slobodan M Jankovic, Marina J Kostić, Miloš N Milosavljević, Marko J Milosavljević, Valentina D Opančina
Antimicrobial treatment of Kocuria kristinae invasive infections: Systematic review. Journal of chemotherapy (Florence, Italy) 31 (3) (2019)
Marina Kostić, Miloš N Milosavljević, Srđan Stefanović, Goran Ranković, Slobodan M Jankovic
Cost-utility of tafenoquine vs. primaquine for the radical cure (prevention of relapse) of Plasmodium vivax malaria. Journal of chemotherapy (Florence, Italy) 32 (1) (2019)
Slobodan M Jankovic, Danka Tešić, Jelena Anđelković, Marina J Kostić
Profile of evolocumab and its cost-effectiveness in patients with high cardiovascular risk: literature review. Expert review of pharmacoeconomics & outcomes research 18 (5) (2018)
Slobodan M Jankovic, Dobrivoje Stojadinovic, Miroslav Stojadinovic, Snezana V Jankovic, Janko M Djuric, Isidora Stojic, Marina Kostic
Angiotensin Receptor Blocker Losartan Inhibits Spontaneous Motility of Isolated Human Ureter. European journal of drug metabolism and pharmacokinetics 41 (6) (2018)
Ana V Pejcic, Slobodan M Jankovic, Valentina Opančina, Goran Babić, Miloš Milosavljević
Drug-drug interactions in patients receiving hematopoietic stem cell transplantation. Expert opinion on drug metabolism & toxicology 15 (1) (2018)
Slobodan M Jankovic, Gordana V Antonijevic, Ivana R Vasic, Marija N Zivkovic-Radojevic, Snjezana N Mirkovic, Bosko V Nikolic, Valentina D Opancina, Srdjan S Putnik, Ljiljana R Radoicic, Katarina M Raspopovic, Dragan R Stanojevic, Sladjana D Teofilov, Katarina V Tomasevic, Vesela Radonjic
A rating instrument for fear of hospitalisation. Journal of clinical nursing 27 (7-8) (2018)
Dejana Ružić Zečević, Marko Folić, Ziyad Tantoush, Milan Radovanović, Goran Babić, Slobodan M Jankovic
Investigational cannabinoids in seizure disorders, what have we learned thus far? Expert opinion on investigational drugs 27 (6) (2018)
Ana V Pejcic, Slobodan M Jankovic, Goran Davidović
Drug-drug interactions in patients with acute coronary syndrome across phases of treatment. Internal and emergency medicine 14 (3) (2018)
Srđan Stefanović, Slobodan M Jankovic, Milan Novaković, Marko Milosavljević, Marko Folić
Pharmacodynamics and common drug-drug interactions of the third-generation antiepileptic drugs. Expert opinion on drug metabolism & toxicology 14 (2) (2017)
Jasmina R Milovanović, Slobodan M Jankovic, Ana V Pejcic, Miloš Milosavljević, Valentina Opančina, Vesela Radonjić, Zoran Protrka, Marina Kostić
Evaluation of brivaracetam: a new drug to treat epilepsy. Expert opinion on pharmacotherapy 18 (13) (2017)

Slobodan M Jankovic.css-eqlu8i{font-size:small;padding-left:4px;} (Slobodan Janković, Slobodan M Janković, Slobodan Jankovic)

Publication Activity (10 Years)

Top Topics

Top Venues

Slobodan M Jankovic (Slobodan Janković, Slobodan M Janković, Slobodan Jankovic)